Medical comorbidity in women and men with schizophrenia: a population-based controlled study
about
Review of the evidence: prevalence of medical conditions in the United States population with serious mental illnessThe role of family therapy in the management of schizophrenia: challenges and solutionsPharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.Effects of plasma magnesium and prolactin on quantitative ultrasound measurements of heel bone among schizophrenic patients.A behavioral weight-loss intervention in persons with serious mental illnessThe predictability of claim-data-based comorbidity-adjusted models could be improved by using medication dataPaliperidone ER: a review of the clinical trial data.Care for patients with severe mental illness: the general practitioner's role perspective.Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care.Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.Development and Reliability Testing of a Health Action Process Approach Inventory for Physical Activity Participation among Individuals with Schizophrenia.Care provided by general practitioners to patients with psychotic disorders: a cohort studyPhysical disease in schizophrenia: a population-based analysis in Spain.The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness.Lifetime manic spectrum episodes and all-cause mortality: 26-year follow-up of the NIMH Epidemiologic Catchment Area StudyPromoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant gliomaChronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder.Differential cardiac effects of aerobic interval training versus moderate continuous training in a patient with schizophrenia: a case report.Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis.Pattern of mortality in a sample of Maryland residents with severe mental illnessPaliperidone: a review of clinical trial data and clinical implications.Making room for mental health in the medical homePreventive medical services use among community mental health patients with severe mental illness:the influence of gender and insurance coverageDisparities in safe sex counseling & behavior among individuals with substance dependence: a cross-sectional studyPhysical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Association between schizophrenia and urinary calculi: a population-based case-control study.Training peer educators to promote self-management skills in people with serious mental illness (SMI) and diabetes (DM) in a primary health care settingAccuracy of self-reported medical problems in patients with alcohol dependence and co-occurring schizophrenia or schizoaffective disorderDoes colocated care improve access to cardiometabolic screening for patients with serious mental illness?Retinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison of twins discordant for psychotic symptoms and controls.The association between antipsychotic agents and the risk of myocardial infarction: a systematic review.Depression, anxiety, and COPD: the unexamined role of nicotine dependenceSchizophrenia: a pathogenetic autoimmune disease caused by viruses and pathogens and dependent on genes.Benefits of a primary care clinic co-located and integrated in a mental health setting for veterans with serious mental illness.Feasibility and acceptability of patient partnership to improve access to primary care for the physical health of patients with severe mental illnesses: an interactive guide.Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorderFrequency of anemia in chronic psychiatry patients.Association between non-compliance with psychiatric treatment and non-psychiatric service utilization and costs in patients with schizophrenia and related disorders.Improving feedback from outpatient medical appointments attended by escorted psychiatric patients in the North London Forensic ServiceThe psychiatric inpatient physical health assessment sheet (PIPHAS): a useful tool to improve the speed, efficiency, and documentation of physical examination in new psychiatric inpatients.
P2860
Q26849474-2BF9F3E7-DD7F-491C-B880-6A6125E3409CQ27016344-9CB9B511-E992-4E92-9224-2C6A9D49667FQ27692023-DD35026D-D2BE-460E-85A9-63605CF71140Q30493532-B61E1754-21FD-4344-B3D6-316B7F7CF0C0Q30542864-6AAF53C6-2075-4C37-8E13-6BCFBF537ABEQ30698080-75B721E7-1AAA-4FD0-B916-0ABCB10FA302Q33419885-1763A357-7892-4B25-9AF1-9142DA18AE52Q33440011-CF321837-64F0-453B-A4D6-C236E11D4478Q33442059-FFABFF59-2550-4D3C-AA3C-EE12EC46B64AQ33670588-BC955AC1-F9E6-4625-8E9A-EC1E568992FFQ33732122-DF83A659-7DEF-4BA2-9002-4A3BBD198FD9Q33756112-946059DD-A77C-4FB2-B628-70CC9415A8A5Q33761743-6E31B118-CED7-4CCF-9447-9DA28E18F2D0Q33798804-9F08B9E8-AB66-4618-885F-F996B7826320Q33813546-F902D404-0790-4078-9E71-0657FE7E9A67Q33914005-36859504-014B-4D8A-97AE-910F62136F59Q34026166-17B0BEE1-2F51-432B-8F1E-DBEB153E2BCDQ34106281-D06FDDA8-B3CC-4209-B7B3-CF8596142CEEQ34183529-226EDC49-99AA-4B53-BAA5-5BD1771E26A3Q34252921-D9C99B9B-7114-406D-99CD-B47E060AD18FQ34321924-EBBB8862-9E37-4EC3-B147-FDF08163C710Q34371307-5795C423-0EA2-4C1F-B837-A3BD38F53260Q34516296-3505FE1E-CE90-4894-9818-1A5621188F5DQ34527916-F89BE261-F60F-4D74-80CC-2752A586AD8FQ34623350-1488C3F7-FD1C-4F02-9070-9D642F5B0D32Q34625474-F0AE4E39-F707-4A24-ACC0-110E36ECA468Q35221725-FD1D2E2D-8013-4D00-8A40-5A935749FE61Q35376156-C323AE2F-3C18-41C6-90EE-DD08A1008D60Q35529149-5E1D9FA4-F80F-41AA-9871-1B535609B119Q35537155-06144FCB-921B-46E4-B8EA-4C0BC0C3FB05Q35629735-6321D44F-E422-4A70-8A48-1B6954D3C39DQ35693650-E453958D-D037-4E58-939A-2463F6D3EE74Q35909867-9CCB0543-B81C-4313-97E1-BBC9247374EEQ35922395-83BC8FA0-6214-42A3-A7C4-9646BC965599Q36056527-5F574E5C-FB52-4B78-96BE-CBE822FF839FQ36074188-FBFC490B-C25D-4C1A-952B-482A1F1D33F0Q36212937-74067C10-533E-4BD1-869F-DC1147567B68Q36220825-B0CE7AF5-352F-4E23-9BA8-8E918248D495Q36282449-1D651488-C271-4293-8369-576DCD5ACF64Q36282575-ADF1B25E-28F3-47C2-B039-D9C62170BF79
P2860
Medical comorbidity in women and men with schizophrenia: a population-based controlled study
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Medical comorbidity in women a ...... ulation-based controlled study
@ast
Medical comorbidity in women a ...... ulation-based controlled study
@en
type
label
Medical comorbidity in women a ...... ulation-based controlled study
@ast
Medical comorbidity in women a ...... ulation-based controlled study
@en
prefLabel
Medical comorbidity in women a ...... ulation-based controlled study
@ast
Medical comorbidity in women a ...... ulation-based controlled study
@en
P2093
P2860
P1476
Medical comorbidity in women a ...... ulation-based controlled study
@en
P2093
Caroline P Carney
Laura Jones
Robert F Woolson
P2860
P304
P356
10.1111/J.1525-1497.2006.00563.X
P577
2006-11-01T00:00:00Z
P5875
P6179
1035184755